Ensign Group (ENSG) on Buyout Binge to Boost Capabilities
The Ensign Group, Inc. ENSG has acquired four skilled nursing facilities in Dallas, TX. Effective Dec 1, 2019, the purchases will be subject to long-term, triple net leases with purchase options following year five of the lease.
The acquisitions include Crestwood Health and Rehabilitation Center; Beacon Harbor Healthcare and Rehabilitation; Rowlett Health and Rehabilitation Center plus Pleasant Manor Healthcare and Rehabilitation. These new deals will fortify its current presence in Dallas, thereby strengthening its overall portfolio. The company looks to enrich customer experience and provide better medical care for improved health outcomes by means of these initiatives.
On the same day, Ensign Group also purchased the real estate and operations of Mission Hills Post Acute in Mesa, AZ, which will further bolster its portfolio. This tactical move will help the company cater to the unique needs of the community.
With these takeovers, Ensign Group now has a portfolio of 213 skilled nursing operations, 24 of which are assisted living operations across 13 states. Additionally, the company owns the real estate of 89 healthcare operations. Management announced that it will continue to seek transactions to acquire real estate and lease both well-performing and struggling skilled nursing operations plus assisted living and other healthcare related businesses throughout the United States.
In September, the company bought the real estate and operations of Temple View Transitional Care Center in Rexburg, ID. With an array of consolidations made in the past decade, Ensign Group now boasts a strong inorganic growth story. It has been successful in integrating businesses by acquiring real estate or leasing post-acute care operations and transforming the same into market leaders. With each integration, the company whetted its efficiency, both clinically and financially. Therefore, we expect all these buyouts to bode well in the long term.
Shares of this Zacks Rank #4 (Sell) stock have lost 5.2% in a year’s time, narrower than its industry’s decline of 12.9%.
Stocks to Consider
Investors interested in the medical sector might consider some better-ranked stocks like Select Medical Holdings Corporation SEM, WellCare Health Plans, Inc. WCG and Genesis Healthcare, Inc. GEN. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Select Medical Holdings operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers. In the trailing four quarters, the company’s average beat was 11.1%. The stock sports a Zacks Rank #1.
WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 17.3% in the preceding four quarters. It carries a Zacks Rank #2 (Buy).
Genesis Healthcare operates skilled nursing facilities and assisted/senior living centers. In the last four quarters, the company delivered average beat of 80.9%. It has a Zacks Rank of 1.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Click to get this free report
Select Medical Holdings Corporation (SEM): Free Stock Analysis Report
WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report
Genesis Healthcare, Inc. (GEN): Free Stock Analysis Report
The Ensign Group, Inc. (ENSG): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.